Incyte Corporation (INCY) Stock Overview
NASDAQ · Healthcare · Biotechnology
About Incyte Corporation
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute…
Source: Yahoo Finance
Sector & Industry
Incyte Corporation operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Incyte Corporation at a Glance
| Company | Incyte Corporation |
| Ticker | INCY |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $117.25 |
| Market cap | $23.42B |
| P/E ratio (trailing) | 16.56 |
| EPS (trailing) | $7.08 |
| 52-week high | $119.60 |
| 52-week low | $67.17 |
| Dividend yield | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 2,844 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
What is Incyte Corporation's P/E ratio?
Incyte Corporation (INCY) has a trailing P/E ratio of 16.56 as of our latest data snapshot.
What is Incyte Corporation's market cap?
Incyte Corporation's market capitalisation is $23.42B based on the most recent snapshot.
What is INCY's 52-week range?
Over the past 52 weeks, INCY has traded between $67.17 and $119.60.
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →A dedicated finance calculator for TVM, NPV and rate-of-return work.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Related Healthcare Stocks
Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: